The agency was expected to rule on whether or not to approve the vaccine, Ervebo, by March 2020. The vaccine protects against Zaire ebolavirus, but not other strains of the virus or the related Marburg virus.
The agency is expected to rule on the vaccine by March 14 of next year. The company has shipped nearly a quarter of 1 million doses of the vaccine to the WHO for countries facing outbreaks like the Democratic Republic of the Congo.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The San Diego company, which initially gained attention for successfully treating Ebola patients, has turned its focus on exosomes which play a role in immune system suppression and the spread of cancerous cellular material.
Merck's investigational Ebola-Zaire vaccine protected 100 percent of patients enrolled in a creative study design, according to data published in The Lancet on Thursday. Efforts to stockpile the drug are already underway.
Prosetta Biosciences says it'll use the proceeds mostly for more antiviral R&D. It has an assembly line approach to producing a series of compounds that alter the assembly of the viral capsid.
Also, Dell jumped into the medical imaging market with its Dell medical Review 24 Monitor and Novo Nordisk said all of its global manufacturing facilities will run on electricity generated from renewable sources by 2020.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Right on the heels of a fast track designation from the FDA, San Diego startup Mapp Biopharmaceutical gets orphan drug status from European regulators for its Ebola drug, ZMapp.
CVS and IBM partnership to spot declining health in pharmacy customers, GE Healthcare is investing $1B in healthcare provider education.
The best way to prevent the spread of Ebola might end up coming in a nontraditional form.
The new rapid diagnostic test, developed by Corgenix, is called the ReEBOV Antigen Rapid Test kit, which can be done at the bedside with a drop of blood.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Updates on the Ebola epidemic have largely faded from the news. Unfortunately, the fight to contain the lethal virus is not over. The AFP reported that an new Ebola outbreak hit Sierra Leone, quashing hopes that the deadly epidemic had finally been contained. Three new cases of Ebola have been identified in the past week in […]
Commercial airplanes have pretty efficient air filtration systems, but could they be improved with the help of a teenager?
OraSure - maker of a wide range of diagnostics - is getting funding for this Ebola prototype testing device from BARDA. It will help push the Ebola test further down the regulatory pathway.
Some FDA approved drugs used for a variety of conditions could potentially be effective in treating Ebola in its early stages.
Bad news about ebola. Good news for Merck and its skin cancer treatment. And the wellness industry continues to crumble - but who lets facts get in the way? Read today's MedCity Morning Read.